Back to search
IE

IE · IE · IE-PA-EU/1/23/1730/001

Briumvi 150 mg Concentrate for solution for infusion

ATC L04AG14

Last synced from HPRA (Ireland) on

Identification

ManufacturerNeuraxpharm Pharmaceuticals S.L.
CountryIE (IE)
ATC codeL04AG14
Dispensing
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026

Packs · 1

  • ie_pa_number
    EU/1/23/1730/001

Annotations

No annotations yet.

Raw payload (JSON)
{
  "form": "Concentrate for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "L04",
    "L04AG14"
  ],
  "strength": null,
  "pa_number": "EU/1/23/1730/001",
  "substances": [
    "Ublituximab"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "31/05/2023",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

Related drugs

Other records sharing ATC code L04AG14.

Access this data programmatically

Query Briumvi 150 mg Concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.